Sepracor
Sepracor Announces Patent Interference Proceedings and Schedule Against Wyeth for Claims Related to O-desmethylvenlafaxine Succinate Marketed as PRISTIQ®
Published in Medical Patent Law Weekly, May 6th, 2009
Sepracor Inc. (Nasdaq: SEPR) announced that the Board of Patent Appeals and Interferences (BPAI) of the U.S. Patent and Trademark Office has combined three patent interferences into a single interference between Sepracor and Wyeth and set a date for oral arguments. The interference seeks to determine the priority of inventorship of claims directed to racemic O-desmethylvenlafaxine (ODMV) succinate. Wyeth markets racemic ODMV succinate in the U.S. under the brand name PRISTIQ® for the treatment of major depressive disorder in adults.
The interference is between Wyeth’s U.S. patents 6,673,838 and 7,291,347, the two patents listed in the FDA’s publication entitled Approved...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Adura Systems, Inc.
Adura Systems Introduces New Era Electric Powertrain - Agile IP
Agile IP Helps Secures Trademark for Seagreens’ Seaweed Products - Albert Einstein College of Medicine
Einstein researchers devise a fast and sensitive way to detect ricin - Alnylam Pharmaceuticals, Inc.
Alnylam Announces Allowance in Europe of New Fundamental Patent Broadly Covering RNAi Therapeutics - Arbitron Inc.
Taher G. Behbehani Named EVP, Chief Strategy and Business Development Officer - ARIAD Pharmaceuticals, Inc.
Preclinical Data Presented on ARIAD’s Investigational mTOR Inhibitor, Deforolimus, in Lung Cancer and Other Solid Tumor Models - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
